179 related articles for article (PubMed ID: 38524288)
1. The Heterogeneity of Symptom Burden and Fear of Progression Among Kidney Transplant Recipients: A Latent Class Analysis.
Zhang Y; Liu S; Miao Q; Zhang X; Wei H; Feng S; Li X
Psychol Res Behav Manag; 2024; 17():1205-1219. PubMed ID: 38524288
[TBL] [Abstract][Full Text] [Related]
2. The Mediating Role of Self-Perceived Burden Between Social Support and Fear of Progression in Renal Transplant Recipients: A Multicenter Cross-Sectional Study.
Liu S; Zhang Y; Miao Q; Zhang X; Jiang X; Chang T; Li X
Psychol Res Behav Manag; 2023; 16():3623-3633. PubMed ID: 37693331
[TBL] [Abstract][Full Text] [Related]
3. Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study.
Veltkamp DMJ; Wang Y; Meuleman Y; Dekker FW; Michels WM; van der Boog PJM; de Vries APJ
Nephrol Dial Transplant; 2023 Jun; 38(7):1707-1718. PubMed ID: 36708170
[TBL] [Abstract][Full Text] [Related]
4. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
[TBL] [Abstract][Full Text] [Related]
5. Relationship between fear of progression and symptom burden, disease factors and social/family factors in patients with stage-IV breast cancer in Shandong, China.
Lu Q; Liu Q; Fang S; Ma Y; Zhang B; Li H; Song L
Cancer Med; 2024 Feb; 13(4):e6749. PubMed ID: 38457242
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with fear of progression in chinese cancer patients: sociodemographic, clinical and psychological variables.
Yang Y; Sun H; Liu T; Zhang J; Wang H; Liang W; Chen Y; Zhang B
J Psychosom Res; 2018 Nov; 114():18-24. PubMed ID: 30314574
[TBL] [Abstract][Full Text] [Related]
7. Association between fear of progression and sleep quality in patients with chronic heart failure: A cross-sectional study.
Xiong J; Qin J; Gong K
J Adv Nurs; 2023 Aug; 79(8):3082-3091. PubMed ID: 36978259
[TBL] [Abstract][Full Text] [Related]
8. Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer.
Dinkel A; Marten-Mittag B; Kremsreiter K
Front Psychol; 2021; 12():648623. PubMed ID: 34456783
[No Abstract] [Full Text] [Related]
9. Chemotherapy-related symptoms in children with leukemia: application of latent profile analysis and network analysis.
Wang M; Fang J; Hu X; Cai T; Wu F; Lin Y
Support Care Cancer; 2024 Mar; 32(3):207. PubMed ID: 38436749
[TBL] [Abstract][Full Text] [Related]
10. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
11. Fear of Progression is Determined by Anxiety and Self-Efficacy but not Disease-Specific Parameters in Patients with Parkinson's Disease: Preliminary Data from a Multicenter Cross-Sectional Study.
Folkerts AK; Haarmann L; Nielsen J; Saliger J; Eschweiler M; Karbe H; Allert N; Vida V; Trenkwalder C; Kruse A; Oelsner H; Ebersbach G; Kalbe E
J Parkinsons Dis; 2022; 12(8):2543-2553. PubMed ID: 36189603
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients.
Oguntola SO; Hassan MO; Duarte R; Dix-Peek T; Dickens C; Olorunfemi G; Vachiat A; Paget G; Manga P; Naicker S
Int J Nephrol Renovasc Dis; 2018; 11():187-193. PubMed ID: 30038514
[TBL] [Abstract][Full Text] [Related]
13. Latent Class Analysis of Symptom Burden Among Seriously Ill Adults at the End of Life.
Murali KP; Yu G; Merriman JD; Vorderstrasse A; Kelley AS; Brody AA
Nurs Res; 2021 Nov-Dec 01; 70(6):443-454. PubMed ID: 34393192
[TBL] [Abstract][Full Text] [Related]
14. The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study.
Li B; Lin X; Chen S; Qian Z; Wu H; Liao G; Chen H; Kang Z; Peng J; Liang G
BMC Public Health; 2024 Feb; 24(1):440. PubMed ID: 38347483
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk symptom cluster burden group among midlife peri-menopausal and post-menopausal women with metabolic syndrome using latent class growth analysis.
Min SH; Docherty SL; Im EO; Hu X; Hatch D; Yang Q
Womens Health (Lond); 2023; 19():17455057231160955. PubMed ID: 36999312
[TBL] [Abstract][Full Text] [Related]
16. Psychometric validation of the fear of progression questionnaire-short form in acute pancreatitis patients.
Ma S; Yang X; Xiang S; Lu G; Gong W; Chen W
Heliyon; 2023 Aug; 9(8):e19060. PubMed ID: 37654456
[TBL] [Abstract][Full Text] [Related]
17. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
18. Fear of progression in parents of childhood cancer survivors: prevalence and associated factors.
Peikert ML; Inhestern L; Krauth KA; Escherich G; Rutkowski S; Kandels D; Schiekiera LJ; Bergelt C
J Cancer Surviv; 2022 Aug; 16(4):823-833. PubMed ID: 34302272
[TBL] [Abstract][Full Text] [Related]
19. Developing a model for measuring fear of pain in Norwegian samples: The Fear of Pain Questionnaire Norway.
Vambheim SM; Lyby PS; Aslaksen PM; Flaten MA; Åsli O; Bjørkedal E; Martinussen LM
Scand J Pain; 2017 Oct; 17():425-430. PubMed ID: 29129465
[TBL] [Abstract][Full Text] [Related]
20. The relationship between symptom perception and fear of progression in patients with chronic heart failure: a multiple mediation analysis.
Xiong J; Qin J; Zheng G; Gao Y; Gong K
Eur J Cardiovasc Nurs; 2023 Sep; 22(6):638-646. PubMed ID: 36748202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
